HeartBeam Inc. and AccurKardia Collaborate to Enhance Remote Cardiac Monitoring
June 17th, 2025 1:05 PM
By: Newsworthy Staff
HeartBeam Inc. partners with AccurKardia to integrate FDA-cleared ECG analysis software into its portable 3D ECG device, aiming to improve arrhythmia detection and management through automated insights.

The collaboration between HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia marks a significant step forward in the field of remote cardiac monitoring. By integrating AccurKardia's FDA-cleared AccurECG(TM) software into HeartBeam's innovative, cable-free 3D ECG device, the partnership is set to revolutionize how cardiac arrhythmias are detected and managed outside traditional clinical settings. This development is particularly timely, given the growing need for accessible cardiac care solutions amidst a decline in access to cardiology specialists across the United States.
HeartBeam's device, notable for its credit card-sized portability, captures electrical signals from the heart in three non-coplanar directions, synthesizing them into a 12-lead ECG. The addition of AccurECG's real-time, device-agnostic rhythm analysis capability will provide automated diagnostic feedback, enabling faster response to cardiac events. This integration not only enhances the commercial offering of HeartBeam but also underscores the potential of combining cutting-edge technologies to address critical healthcare challenges.
The implications of this collaboration extend beyond technological innovation. By empowering patients with clinical-grade cardiac data outside conventional healthcare environments, the combined platform has the potential to significantly improve patient outcomes. Faster detection and management of arrhythmias could lead to timely interventions, reducing the risk of complications and hospitalizations. Furthermore, this partnership highlights the importance of strategic collaborations in advancing healthcare technology, offering a scalable solution that could benefit millions of individuals at risk of cardiac conditions.
As the healthcare industry continues to evolve towards more patient-centered and accessible solutions, the HeartBeam and AccurKardia collaboration serves as a beacon of progress. It not only addresses a pressing need in cardiac care but also sets a precedent for how technology can be leveraged to overcome barriers to healthcare access. The combined platform's focus on automation and remote monitoring aligns with broader trends in digital health, pointing towards a future where advanced medical diagnostics are available anytime, anywhere.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
